Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...

In a noteworthy financial move, William Blair Investment Management LLC has escalated its holdings in Live Nation Entertainment, Inc. (NYSE: LYV) by an impressive 18.7% in the fourth quarter, as ...

Stock analysts at William Blair increased their Q1 2025 earnings estimates for Boeing in a research report issued on ...

Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...

William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued ...

Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...

Stock analysts at William Blair issued their Q1 2026 EPS estimates for shares of NuCana in a research note issued on Thursday ...

Investment analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Five Below in a research note issued to investors on Thursday, March 20th. William Blair analyst ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The main contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...

Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for MiNK Therapeutics in a ...